Pharma Equity Group A/S (OCSE:PEG) EBIT per Share : kr-0.03 (TTM As of Mar. 2024)

View and export this data going back to 2003. Start your Free Trial

What is Pharma Equity Group A/S EBIT per Share?

Pharma Equity Group A/S's EBIT per Share for the three months ended in Mar. 2024 was kr-0.01. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 was kr-0.03.

During the past 3 years, the average EBIT per Share Growth Rate was 60.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Pharma Equity Group A/S's EBIT per Share or its related term are showing as below:

OCSE:PEG' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -62.7 Med: 34.15 Max: 69.9
Current: 60.8

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Pharma Equity Group A/S was 69.90% per year. The lowest was -62.70% per year. And the median was 34.15% per year.

OCSE:PEG's 3-Year EBIT Growth Rate is ranked better than
95.93% of 1301 companies
in the Biotechnology industry
Industry Median: 3.4 vs OCSE:PEG: 60.80

Pharma Equity Group A/S's EBIT for the three months ended in Mar. 2024 was kr-6.83 Mil.

Pharma Equity Group A/S EBIT per Share Historical Data

The historical data trend for Pharma Equity Group A/S's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharma Equity Group A/S EBIT per Share Chart

Pharma Equity Group A/S Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

-0.71

-1.03

0.10

-0.01

-0.02

Pharma Equity Group A/S Quarterly Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBIT per Share	Get a 7-Day Free Trial															-	-	-	-0.01	-0.01

Pharma Equity Group A/S EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Pharma Equity Group A/S's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-25.279	/	1088.551
=	-0.02

Pharma Equity Group A/S's EBIT per Share for the quarter that ended in Mar. 2024 is calculated as

	EBIT per Share		(Q: Mar. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-6.828	/	1039.497
=	-0.01

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.03

Pharma Equity Group A/S (OCSE:PEG) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Pharma Equity Group A/S EBIT per Share Related Terms

Thank you for viewing the detailed overview of Pharma Equity Group A/S's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharma Equity Group A/S (OCSE:PEG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharma Equity Group A/S (OCSE:PEG) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

Slotsmarken 18, 2.th., Horsholm, DNK, DK-2970

Website

https://www.pharmaequitygroup.com

Pharma Equity Group A/S is an investment company specializing in the life science industry. The group is focused on an early investment in various life science companies that develops technologies and therapies that have the potential to improve human health and quality of life. The group specializes in early-stage investments in biotechnology, that are developing novel therapies for unmet medical needs. Its portfolio consists of companies dedicated to developing novel, effective treatments for diseases with patient and social impact for which current therapy is lacking or in need of improvement.